These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18971847)

  • 21. Subfoveal hemorrhage after verteporfin photodynamic therapy in treatment of choroidal neovascularization.
    Gelisken F; Inhoffen W; Karim-Zoda K; Grisanti S; Partsch M; Voelker M; Bartz-Schmidt KU
    Graefes Arch Clin Exp Ophthalmol; 2005 Mar; 243(3):198-203. PubMed ID: 15258778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Encouraging results of photodynamic therapy with Visudyne in a clinical patient material of age-related macular degeneration.
    Frennesson CI; Nilsson SE
    Acta Ophthalmol Scand; 2004 Dec; 82(6):645-50. PubMed ID: 15606458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study.
    Sharp DM; Lai S; Markey CM
    Clin Exp Ophthalmol; 2007; 35(1):24-31. PubMed ID: 17300567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).
    Costa RA; Jorge R; Calucci D; Melo LA; Cardillo JA; Scott IU
    Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1273-80. PubMed ID: 17333238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
    Augustin AJ; Schmidt-Erfurth U
    Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occult with no classic choroidal neovascularization secondary to age-related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin.
    Nicolò M; Ghiglione D; Lai S; Nasciuti F; Cicinelli S; Calabria G
    Retina; 2006 Jan; 26(1):58-64. PubMed ID: 16395140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy.
    Moshfeghi DM; Kaiser PK; Grossniklaus HE; Sternberg P; Sears JE; Johnson MW; Ratliff N; Branco A; Blumenkranz MS; Lewis H
    Am J Ophthalmol; 2003 Mar; 135(3):343-50. PubMed ID: 12614752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photodynamic therapy with verteporfin for peripapillary choroidal neovascularization.
    Rosenblatt BJ; Shah GK; Blinder K
    Retina; 2005 Jan; 25(1):33-7. PubMed ID: 15655438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photodynamic therapy with verteporfin following transpupillary thermotherapy for CNV evolving from an initially occult to a predominantly classic form, in patients with AMD.
    Hamon F; Goeminne P
    Semin Ophthalmol; 2001 Dec; 16(4):223-32. PubMed ID: 15513445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occult with no classic subfoveal choroidal neovascular lesions in age-related macular degeneration: clinically relevant natural history information in larger lesions with good vision from the Verteporfin in Photodynamic Therapy (VIP) Trial: VIP Report No. 4.
    Pieramici DJ; Bressler SB; Koester JM; Bressler NM
    Arch Ophthalmol; 2006 May; 124(5):660-4. PubMed ID: 16682587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.
    Lazic R; Gabric N
    Ophthalmology; 2007 Jun; 114(6):1179-85. PubMed ID: 17544776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of verteporfin for treatment of subfoveal choroidal neovascular membranes associated with age-related macular degeneration.
    Gaynes BI; Fiscella RG
    Expert Opin Drug Saf; 2004 Jul; 3(4):345-61. PubMed ID: 15268651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Choroidal ischemia after photodynamic therapy with verteporfin for choroidal neovascularization.
    Isola V; Pece A; Parodi MB
    Am J Ophthalmol; 2006 Oct; 142(4):680-3. PubMed ID: 17011867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1.
    Blinder KJ; Bradley S; Bressler NM; Bressler SB; Donati G; Hao Y; Ma C; Menchini U; Miller J; Potter MJ; Pournaras C; Reaves A; Rosenfeld PJ; Strong HA; Stur M; Su XY; Virgili G; ;
    Am J Ophthalmol; 2003 Sep; 136(3):407-18. PubMed ID: 12967792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.
    Chan WM; Lam DS; Lai TY; Liu DT; Li KK; Yao Y; Wong TH
    Ophthalmology; 2004 Aug; 111(8):1576-84. PubMed ID: 15288991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical trial of verteporfin photodynamic therapy in Chinese age-related macular degeneration with subfoveal predominant choroidal neovascularization patients].
    Chen YX; Ge J; Yan M; Jin CJ; Zhang MX; Dong FT; Lu F; Zhang CF; Zhao JL
    Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):198-205. PubMed ID: 17605900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photodynamic therapy for age-related macular degeneration treatment: epidemiological and clinical analysis of a long-term study.
    Mataix J; Desco MC; Palacios E; Garcia-Pous M; Navea A
    Ophthalmic Surg Lasers Imaging; 2009; 40(3):277-84. PubMed ID: 19485292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update.
    Verteporfin Roundtable Participants
    Retina; 2005; 25(2):119-34. PubMed ID: 15689800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration.
    Hariprasad SM; Shah GK
    Ophthalmic Surg Lasers Imaging; 2005; 36(3):258-60. PubMed ID: 15957487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2.
    Bressler NM
    Am J Ophthalmol; 2002 Jan; 133(1):168-9. PubMed ID: 11755871
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.